Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    PPARγ Ligand–induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast Cancers

    Access Status
    Fulltext not available
    Authors
    Chen, L.
    Yuan, Y.
    Kar, S.
    Kanchi, M.
    Arora, S.
    Kim, J.
    Koh, P.
    Yousef, E.
    Samy, R.
    Shanmugam, M.
    Tan, T.
    Shin, S.
    Arfuso, Frank
    Shen, H.
    Yang, H.
    Goh, B.
    Park, J.
    Gaboury, L.
    Lobie, P.
    Sethi, Gautam
    Lim, L.
    Kumar, Alan
    Date
    2017
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Chen, L. and Yuan, Y. and Kar, S. and Kanchi, M. and Arora, S. and Kim, J. and Koh, P. et al. 2017. PPARγ Ligand–induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast Cancers. Molecular Cancer Therapeutics. 16 (11): pp. 2528-2542.
    Source Title
    Molecular Cancer Therapeutics
    DOI
    10.1158/1535-7163.MCT-16-0739
    ISSN
    1538-8514
    School
    School of Pharmacy and Biomedical Sciences
    URI
    http://hdl.handle.net/20.500.11937/60223
    Collection
    • Curtin Research Publications
    Abstract

    Metastatic breast cancer is still incurable so far; new specifically targeted and more effective therapies for triple-negative breast cancer (TNBC) are required in the clinic. In this study, our clinical data have established that basal and claudin-low subtypes of breast cancer (TNBC types) express significantly higher levels of Annexin A1 (ANXA1) with poor survival outcomes. Using human cancer cell lines that model the TNBC subtype, we observed a strong positive correlation between expression of ANXA1 and PPAR?. A similar correlation between these two markers was also established in our clinical breast cancer patients' specimens. To establish a link between these two markers in TNBC, we show de novo expression of ANXA1 is induced by activation of PPAR? both in vitro and in vivo and it has a predictive value in determining chemosensitivity to PPAR? ligands. Mechanistically, we show for the first time PPAR?-induced ANXA1 protein directly interacts with receptor interacting protein-1 (RIP1), promoting its deubiquitination and thereby activating the caspase-8-dependent death pathway. We further identified this underlying mechanism also involved a PPAR?-induced ANXA1-dependent autoubiquitination of cIAP1, the direct E3 ligase of RIP1, shifting cIAP1 toward proteosomal degradation. Collectively, our study provides first insight for the suitability of using drug-induced expression of ANXA1 as a new player in RIP1-induced death machinery in TNBCs, presenting itself both as an inclusion criterion for patient selection and surrogate marker for drug response in future PPAR? chemotherapy trials. Mol Cancer Ther; 16(11); 2528-42. ©2017 AACR.

    Related items

    Showing items related by title, author, creator and subject.

    • PPAR gamma Ligand-induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast Cancers
      Chen, L.; Yuan, Y.; Kar, S.; Kanchi, M.; Arora, S.; Kim, J.; Koh, P.; Yousef, E.; Samy, R.; Shanmugam, M.; Tan, T.; Shin, S.; Arfuso, Frank; Shen, H.; Yang, H.; Goh, B.; Park, J.; Gaboury, L.; Lobie, P.; Sethi, G.; Lim, L.; Kumar, Alan Prem (2017)
      Metastatic breast cancer is still remain incurable so far, new specifically targeted and more effective therapies for triple negative breast cancer (TNBC) are required in the clinic. In this study, our clinical data has ...
    • Annexin-A1 enhances breast cancer growth and migration by promoting alternative macrophage polarization in the tumour microenvironment
      Moraes, L.; Kar, S.; Foo, S.; Gu, T.; Toh, Y.; Ampomah, P.; Sachaphibulkij, K.; Yap, G.; Zharkova, O.; Lukman, H.; Fairhurst, A.; Kumar, Alan Prem; Lim, L. (2017)
      © 2017 The Author(s). Macrophages are potent immune cells with well-established roles in the response to stress, injury, infection and inflammation. The classically activated macrophages (M1) are induced by lipopolysaccharide ...
    • Anticancer activity of thymoquinone in breast cancer cells: Possible involvement of PPAR-γ pathway
      Woo, C.; Loo, S.; Gee, V.; Yap, C.; Sethi, G.; Kumar, Alan Prem; Benny Tan, K. (2011)
      Thymoquinone (TQ), an active ingredient of Nigella sativa, has been reported to exhibit anti-oxidant, anti-inflammatory and anti-tumor activities through mechanism(s) that is not fully understood. In this study, we report ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.